---
title: "DANAHER MEDICAL ApS — Financial report"
canonical_url: "https://datapublica.dk/en/companies/27559522-danaher-medical-aps/financials"
locale: "en"
route_type: "company_financials"
robots: "index,follow"
content_access: "standard"
---

# DANAHER MEDICAL ApS — Financial report

CVR 27559522

## Latest financial period

- 2025 • 2025-01-01 • 2025-12-31 • entity • DKK • 226822000 • 226685000 • 92891000 • 74269000 • 798707000 • 642032000 • 0

## Financial history

- 2024 • 2024-01-01 • 2024-12-31 • entity • DKK • 223362000 • 223263000 • 93366000 • 77496000 • 954181000 • 767763000 • 0

- 2023 • 2023-01-01 • 2023-12-31 • entity • DKK • 218678000 • 218092000 • 91978000 • 75368000 • 1104051000 • 890267000 • 0

- 2022 • 2022-01-01 • 2022-12-31 • entity • DKK • 208581000 • 208016000 • 85575000 • 65737000 • 1252775000 • 1014898000

- 2021 • 2021-01-01 • 2021-12-31 • entity • DKK • 192957000 • 192360000 • 73485000 • 55991000 • 1410044000 • 1149160000

- 2020 • 2020-01-01 • 2020-12-31 • entity • DKK • 186354000 • 185763000 • 70351000 • 53576000 • 1979174000 • 1693169000

- 2019 • 2019-01-01 • 2019-12-31 • entity • DKK • 170424000 • 169531000 • 57480000 • 44552000 • 1947732000 • 1639591000

- 2018 • 2018-01-01 • 2018-12-31 • entity • DKK • 154461000 • 153609000 • 44822000 • 34679000 • 1923589000 • 1595039000

## Annual report highlights

- primary activities • Business reviewThe objectives of the Company are to carry on commercial business as well as financing and investment.

In December 2009, the Company acquired intangible assets from Radiometer Medical ApS. The Company's principal activity now consists of the outlicensing of these assets to other Danaher group entities. • entity

- development in activities and financial affairs • Financial review The Company's income statement for the year ended 31 December 2025 shows a profit of DKK 74.270 thousand, and the balance sheet at 31 December 2025 shows equity of DKK 642.033 thousand.

Income relates to licensing of the acquired intangible fixed assets and the result for the year is considered satisfactory.

During 2025 the Company paid DKK 200 mio. in dividend to it's owner.

In the financial statements for 2024 management expected profit/loss for 2025 to be within a margin of 67-82 mio. DKK. Profit for the year decreased 4% compared to 2024 as a result of decreased intercompany interest income but is still within the expected range. The Revenue from royalties increased due to increased sales by Radiometer Medical ApS in 2025. This is caused by an increase in the number of units sold with the intellectual property. Currency adjustments has slightly positively affected the revenue from royalty. The development is considered satisfactory.

The Board of Executives recommends distribution of the profit as stated under the proposed distribution of profit.

Future expectations

The Company expects earnings on the same level as in the current year. The profit/loss for the year is expected to be within a margin of 65-80 mio. DKK. • entity

- development in activities and financial affairs • Significant changes in the company's activities and financial matters.There have been no significant changes in the activities and financial matters. • entity

- subsequent events • Significant events occurring after the end of the financial yearNo significant events have occurred after the balance sheet date which could significantly affect the Company's financial position. • entity

- subsequent events • No significant events have occured after the end of the financial year which impacts the Company's financial position. • entity

- contingent liabilities • Joint taxation The Company is jointly taxed with Danaher Tax Administration ApS, which is the management company \(Administrationsselskab\) for the Danish joint taxation. The Company is jointly and severally unlimited liable with the other jointly taxed companies for payment of corporation tax and for withholding tax on interest, royalties and dividends.Other ContingenciesThe Company has no other contingent assets or liabilities. • entity